Published Online
on June 11, 2007

A more recent version of this article appeared on August 1, 2007

This Article Full Text (PDF) All Versions of this Article: 50/2/297    most recent HYPERTENSIONAHA.107.092437v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Barbato, J. C. Search for Related Content PubMed PubMed Citation Articles by Barbato, J. C. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Heart Failure Hazardous Substances DB SPIRONOLACTONE Related Collections Congestive Gene regulation Hypertrophy Physiological and pathological control of gene expression Other Vascular biology Related Article

Estrogen Receptor Activation--Good, Aldosterone Receptor Blockade--Beneficial, Communication Between Receptors...Priceless

John C. Barbato^*

From the Cleveland Clinic, Pepper Pike, Ohio.

^* To whom correspondence should be addressed. E-mail: jcb-pad{at}sbcglobal.net.

Related Article:

Both Estrogen Receptor Subtypes, and ß, Attenuate Cardiovascular Remodeling in Aldosterone Salt–Treated Rats

Paula-Anahi Arias-Loza, Kai Hu, Charlotte Dienesch, Anna Maria Mehlich, Simone König, Virginia Jazbutyte, Ludwig Neyses, Christa Hegele-Hartung, Karl Heinrich Fritzemeier, and Theo Pelzer
Hypertension 2007 50: 432-438. [Abstract] [Full Text] [PDF]